A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors
Clinical trial NCT06411301 · WITHDRAWN
Trial details
- NCT number
- NCT06411301
- Sponsor
- Jules Bordet Institute
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2026-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.